A Critical Analysis of the Interpretation of Biochemical Failure in Surgically Treated Patients Using the American Society for Therapeutic Radiation and Oncology Criteria-Reference-Cited by-同舟云学术

A Critical Analysis of the Interpretation of Biochemical Failure in Surgically Treated Patients Using the American Society for Therapeutic Radiation and Oncology Criteria

Published:2002-10 Issue:4 Part 1 Volume:168 Page:1419-1422
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Gretzer Matthew B.¹,Trock Bruce J.¹,Han Misop¹,Walsh Patrick C.¹

Affiliation:

1. From The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference23 articles.

1. Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer;Han;J Urol,2001

2. The value of serum prostate specific antigen determinations before and after radical prostatectomy;Lange;J Urol,1989

3. Is prostate specific antigen of clinical importance in evaluating outcome after radical prostatectomy;Frazier;J Urol,1993

4. The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy;Trapasso;J Urol,1994

5. Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel;Int J Radiat Oncol Biol Phys,1997

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of AUA and phoenix definitions of biochemical failure following permanent brachytherapy for prostate cancer;Brachytherapy;2022-11

2. The Treatments for Low-Risk Prostate Cancer;The Korean Journal of Urological Oncology;2019-04-30

3. Velocity and doubling time of prostate-specific antigen: mathematics can matter;Journal of Investigative Medicine;2016-01-14

4. Is Surgery Still Necessary for Prostate Cancer?;Prostate Cancer;2016

5. Prostate Cancer;Clinical Radiation Oncology;2016